Jafron Biomedical Co Ltd (300529) — Financial Flexibility Index
Jafron Biomedical Co Ltd (300529) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥64.79 Million (operating CF CN¥35.34 Million minus capex CN¥29.45 Million) represents 0% of total liabilities (CN¥2.11 Billion). Check Jafron Biomedical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jafron Biomedical Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Jafron Biomedical Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see Jafron Biomedical Co Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Jafron Biomedical Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Jafron Biomedical Co Ltd. Explore debt repayment capacity of Jafron Biomedical Co Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥893.81 Million | CN¥721.22 Million | CN¥1.94 Billion | ▼ -26.5% |
| 2024 | 0.63x | CN¥1.29 Billion | CN¥1.05 Billion | CN¥2.05 Billion | ▲ +28.9% |
| 2023 | 0.49x | CN¥1.16 Billion | CN¥916.74 Million | CN¥2.39 Billion | ▼ -34.7% |
| 2022 | 0.75x | CN¥1.36 Billion | CN¥883.80 Million | CN¥1.82 Billion | ▼ -40.5% |
| 2021 | 1.25x | CN¥1.79 Billion | CN¥1.25 Billion | CN¥1.43 Billion | ▼ -63.5% |
| 2020 | 3.43x | CN¥1.31 Billion | CN¥957.49 Million | CN¥383.06 Million | ▲ +38.3% |
| 2019 | 2.48x | CN¥804.17 Million | CN¥583.50 Million | CN¥324.13 Million | ▲ +46.8% |
| 2018 | 1.69x | CN¥557.60 Million | CN¥384.08 Million | CN¥330.04 Million | ▲ +9.0% |
| 2017 | 1.55x | CN¥481.82 Million | CN¥304.10 Million | CN¥310.90 Million | ▼ -13.4% |
| 2016 | 1.79x | CN¥207.29 Million | CN¥178.64 Million | CN¥115.81 Million | ▼ -16.3% |
| 2015 | 2.14x | CN¥266.58 Million | CN¥205.18 Million | CN¥124.61 Million | ▼ -8.1% |
| 2014 | 2.33x | CN¥201.64 Million | CN¥137.35 Million | CN¥86.59 Million | ▼ -3.3% |
| 2013 | 2.41x | CN¥196.47 Million | CN¥133.33 Million | CN¥81.60 Million | ▼ -29.7% |
| 2012 | 3.42x | CN¥173.68 Million | CN¥120.25 Million | CN¥50.74 Million | ▲ +14.6% |
| 2011 | 2.99x | CN¥91.64 Million | CN¥77.06 Million | CN¥30.68 Million | — |